Jul 10, 2018

Michael Bloomberg to bring together world leaders for second forum

Bloomberg in London. Photo: Tim P. Whitby/Getty Images for Serpentine Galleries

For the second year in a row, former New York Mayor Michael Bloomberg will convene world leaders and CEOs for a Bloomberg Global Business Forum in New York on September 26 during the United Nations General Assembly.

“The Forum comes at a critical time as tensions around tariffs create economic uncertainty in many industries."
— Michael Bloomberg

The details, per a release:

  • "Heads of state from five continents are already confirmed to attend this year’s Forum."
  • "Supported by Bloomberg Philanthropies, the daylong forum is the sole convening dedicated to encouraging presidents, prime ministers and CEOs to collaborate on trade issues."
  • "Leaders from the public and private sectors and civil society, French President Emmanuel Macron, Secretary-General of the United Nations António Guterres, President of the World Bank Group Jim Yong Kim and ... Michael Bloomberg will host the second One Planet Summit on the afternoon September 26th at the Plaza Hotel."
  • Forum partners: Alphabet Inc./Google CFO Ruth Porat, BNP Paribas CEO Jean-Laurent Bonnafé, Credit Suisse CEO Tidjane Thiam, Dangote Group President/Chief Executive Aliko Dangote, Engie Global CEO Isabelle Kocher, EXOR Chairman and CEO John Elkann, LVMH CEO Bernard Arnault, Mahindra Group Chairman Anand G. Mahindra, Misk Foundation Chairman and His Royal Highness Crown Prince of Saudi Arabia Mohammad bin Salman bin Abdulaziz, and SOHO China Founder and CEO Xin (Shynn) Zhang.

Read the release.

Go deeper

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 5,453,784 — Total deaths: 345,886 — Total recoveries — 2,191,310Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 1,651,254 — Total deaths: 97,850 — Total recoveries: 366,736 — Total tested: 14,163,915Map.
  3. World: Top Boris Johnson aide defends himself after allegations he broke U.K. lockdown — WHO suspends trial of hydroxychloroquine over safety concerns.
  4. 2020: Trump threatens to move Republican convention from North Carolina — Joe Biden makes first public appearance in two months.
  5. Public health: Officials are urging Americans to wear masks over Memorial Day.
  6. Economy: White House economic adviser Kevin Hassett says it's possible the unemployment rate could still be in double digits by November's election — Charities refocus their efforts to fill gaps left by government.
  7. What should I do? Hydroxychloroquine questions answeredTraveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 18 mins ago - Politics & Policy

Joe Biden makes first public appearance in over two months

Photo: Oliver Douliery/AFP via Getty Images

Former Vice President Joe Biden made his first in-person appearance in over two months on Monday to honor Memorial Day by laying a wreath at a Delaware veterans park, AP reports.

Why it matters: Biden, the Democratic Party's presumptive nominee, has taken the unprecedented step of campaigning from his home during the coronavirus pandemic, ever since canceling a rally in Cleveland on March 10.

WHO temporarily suspends trial of hydroxychloroquine over safety concerns

Photo: Fabrice Coffrini/AFP via Getty Images

The World Health Organization is temporarily pausing tests of the anti-malarial drug hydroxychloroquine as a coronavirus treatment in order to review safety concerns, the agency's director-general Tedros Adhanom Ghebreyesu said Monday.

Why it matters: The decision comes after a retrospective review published in The Lancet found that coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm that can lead to sudden cardiac death, compared to those who did nothing.